ATE58479T1 - Albumin-komplex. - Google Patents

Albumin-komplex.

Info

Publication number
ATE58479T1
ATE58479T1 AT86310079T AT86310079T ATE58479T1 AT E58479 T1 ATE58479 T1 AT E58479T1 AT 86310079 T AT86310079 T AT 86310079T AT 86310079 T AT86310079 T AT 86310079T AT E58479 T1 ATE58479 T1 AT E58479T1
Authority
AT
Austria
Prior art keywords
albumin complex
useful substance
albumin
complex
powdery complex
Prior art date
Application number
AT86310079T
Other languages
English (en)
Inventor
Hitoshi Matsumoto
Hisao Kakegawa
Toshio Satoh
Original Assignee
Nippon Hypox Lab Inc
Sato Toshio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP60293451A external-priority patent/JPH0762039B2/ja
Application filed by Nippon Hypox Lab Inc, Sato Toshio filed Critical Nippon Hypox Lab Inc
Application granted granted Critical
Publication of ATE58479T1 publication Critical patent/ATE58479T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT86310079T 1985-12-28 1986-12-23 Albumin-komplex. ATE58479T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP60293451A JPH0762039B2 (ja) 1985-12-28 1985-12-28 粉末状ビタミンe―アルブミン複合体
JP8111886 1986-04-10
EP86310079A EP0231649B1 (de) 1985-12-28 1986-12-23 Albumin-Komplex

Publications (1)

Publication Number Publication Date
ATE58479T1 true ATE58479T1 (de) 1990-12-15

Family

ID=26422164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86310079T ATE58479T1 (de) 1985-12-28 1986-12-23 Albumin-komplex.

Country Status (7)

Country Link
US (1) US5053490A (de)
EP (1) EP0231649B1 (de)
KR (1) KR910004346B1 (de)
AT (1) ATE58479T1 (de)
DE (1) DE3675757D1 (de)
DK (1) DK627086A (de)
ES (1) ES2019067B3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE106250T1 (de) * 1987-07-07 1994-06-15 Hybrisens Ltd Verwendung von antikörper-antigen-wechselwirkung zum schutz oder modulation der biologischen aktivität.
US5686579A (en) * 1988-06-21 1997-11-11 Hybrisens, Ltd. Use of antibody/antigen interactions to protect biologically active proteins and peptides
IL110192A (en) * 1994-07-01 2000-09-28 Israel Mini Ind & Trade Reagent for the determination of acids in oils
US7799365B2 (en) * 2001-04-06 2010-09-21 Burnbrae Farms Limited Liquid egg composition including fish oil with omega-3 fatty acid
KR20060027862A (ko) * 2003-07-09 2006-03-28 제이-오일 밀스, 인코포레이티드 장쇄의 고도로 불포화된 지방산을 함유하는 산화방지 지방또는 오일 조성물
US20050164908A1 (en) * 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
WO2009012785A2 (en) * 2007-07-20 2009-01-29 Nya Hamlet Pharma Ab Complexes of an emulgator and a fatty acid

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB188437A (en) * 1921-09-03 1922-11-16 Richard Threlfall Manufacture of products useful as food or medicine
US2194188A (en) * 1935-06-29 1940-03-19 Borden Co Method of producing vitamin d product
US2628227A (en) * 1949-05-12 1953-02-10 Eastman Kodak Co Water-soluble complex of vitamin e and plasma proteins
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
FR4954M (de) * 1963-11-06 1967-04-03
FR5900M (de) * 1966-10-12 1968-04-29
JPS6046092B2 (ja) * 1974-07-01 1985-10-14 中外製薬株式会社 脳機能障害の改善および予防成分の抽出法
US4195126A (en) * 1977-10-04 1980-03-25 The Board Of Trustees Of The University Of Alabama Albumin-dye complex for fatty acid determination
JPS5716823A (en) * 1980-07-03 1982-01-28 Green Cross Corp:The Live mumps vaccine pharmaceutical and stabilizing method
US4303671A (en) * 1980-07-10 1981-12-01 The Upjohn Company Albumin stabilized prostacyclin
US4395422A (en) * 1981-04-06 1983-07-26 Basf Wyandotte Corporation Spray dried vitamin E powder

Also Published As

Publication number Publication date
EP0231649B1 (de) 1990-11-22
DK627086D0 (da) 1986-12-23
EP0231649A1 (de) 1987-08-12
KR870005644A (ko) 1987-07-06
DK627086A (da) 1987-06-29
KR910004346B1 (ko) 1991-06-26
ES2019067B3 (es) 1991-06-01
US5053490A (en) 1991-10-01
DE3675757D1 (de) 1991-01-03

Similar Documents

Publication Publication Date Title
DK161602C (da) Additivsammensaetning og koncentrat af samme til forbedring af braendselsoliers flydeevne, samt braendselsolie indeholdende additivsammensaetningen
FR2534880B1 (fr) Recipient de stockage de liquide
NO165769C (no) Flytende blekepreparat.
DK629786D0 (da) Nitrogenholdige heterocycler
DK122490A (da) Haeldetud til beholdere
DE3670398D1 (de) Quelle fluessiger metallionen.
IT1123122B (it) Composizioni liquide insetticide contenenti piretroidi sintetici
DK354385A (da) Liposom-kompatibelt overfladeaktivt stof
DK257383A (da) Lagerstabil tablet indeholdende hydrolysefoelsomt aktivt stof
DK456486D0 (da) Fasestabil, flydende skurerensemiddelkomposition
NL7904788A (nl) Dispergerende toevoegsels bevattende smeermiddel- preparaten.
DK349082A (da) Beholdere til opbevaring af blodplader
BR8604420A (pt) Recipiente de compensacao inteirico para liquido de refrigeracao
DE3583867D1 (de) Fluessigkeitsbehaelter.
DE3674352D1 (de) Lagerstabile praeparate von in wasser unloeslichen bis schwerloeslichen feststoffen.
DE3675757D1 (de) Albumin-komplex.
FI840637A7 (fi) Säiliö nestemäisiä formuladieettejä varten.
DE3672772D1 (de) Abgedichteter behaelter.
FI870837A7 (fi) Kaasun tai nesteen varastointiperiaate.
DE3865090D1 (de) Verpackungstechnik von batterien.
DE3686643D1 (de) Fluessiges duengemittel von hohem ernaehrungswert.
BE860039A (fr) Recipient pour la conservation separee de constituants a melanger
DE3667156D1 (de) Abgedichteter behaelter.
NO862174L (no) Borevaeske-additiv inneholdende hoey-pyruvatxantan.
DE3766153D1 (de) Vorbeugung der geruchsabschwaechung von mit organoschwefelverbindungen odorisiertem fluessiggas.